Abstract
Commentary: A Gene-Based Association Method for Mapping Traits Using Reference Transcriptome Data.
Highlights
U.S Department of Health and Human Services, Center for the Clinical Trials Network, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA
Gene expression regulation mechanisms contribute to disease susceptibility, drug response, and the course of many substance-use disorders [1,2,3]
The investigators harnessed the power of large reference transcriptome data sets, such as the Genotype-Tissue Expression (GTEx) Project, the Genetic European Variation in Health and Disease (GEUVADIS), and Depression Genes and Networks (DGN), among others – in which both gene variation and gene expression levels have been measured – to estimate genetically regulated gene expression of single nucleotide polymorphism (SNP)
Summary
Gene expression regulation mechanisms contribute to disease susceptibility, drug response, and the course of many substance-use disorders [1,2,3]. Gamazon et al recently reported development of an innovative gene-based association method to further understanding of gene-expression regulation mechanisms mediating relationships between single nucleotide polymorphism (SNP) variations and phenotypic variability of complex traits [4].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
